Advanced search
Show most relevant results first | Most recent results are first | Show use by person

Results 1-4 of 4 for flu segment:8372057

Joint Oireachtas Committee on Health: Sláintecare Implementation: Discussion (Resumed) (28 Sep 2022)

Mr. Paul Reid: We see a value for them in this regard. As the Deputy mentioned, they more than demonstrated their value in the vaccination programmes. They play a key role in flu vaccination programmes. Not all of them participate, but we would like to see more of them participating and we are encouraging more of them to do so. We see them as part of the primary care service we provide.

Joint Oireachtas Committee on Health: Sláintecare Implementation: Discussion (Resumed) (28 Sep 2022)

Mr. Robert Watt: Nobody knows the demand we are going to see during the winter. That depends on the prevalence of various respiratory diseases. The flu season in the southern hemisphere was quite severe this year and there is always the potential for Covid to re-emerge. We are anticipating a difficult winter. As Mr. Reid and the team can confirm, we have had a high level of attendances...

Joint Oireachtas Committee on Health: Sláintecare Implementation: Discussion (Resumed) (28 Sep 2022)

Martin Conway: My final question is for Mr. Reid. How are the stocks of the flu vaccine this year and how are we doing with stocks of Covid-19 vaccines? Will he reassure people about the flu vaccine? There was a problem with it last year and, obviously, the Covid-19 vaccines are very important.

Joint Oireachtas Committee on Health: Sláintecare Implementation: Discussion (Resumed) (28 Sep 2022)

Mr. Paul Reid: I thank the Senator, including for his earlier comments. We are sufficient with stocks we ordered for the flu vaccine much earlier in the year. The flu campaign will start on 3 October, early next week, and there will be a dual campaign relating to Covid, with the new multivariant vaccine that is available, and the flu vaccine. We have a number of media communications...

   Advanced search
Show most relevant results first | Most recent results are first | Show use by person